Point-of-care (POC) Diagnostics Market to Exhibit a Decent CAGR of 7.3% and Hit USD 23.36 Billion by 2027; Launch of POC Lumella by DiabetOmics to Accelerate Business, states Fortune Business Insights™

Ads